The emergence of long-term survivors in recurrent and metastatic squamous cell head and neck cancer

Purpose of reviewThe systemic therapies available in recurrent and metastatic head and neck squamous cell carcinoma to date are palliative-intent treatments in most cases. However, a small subgroup of patients derives unconventional benefit and become long-term survivors, achieving cure in some case